Caricamento...
Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
BACKGROUND: Majority of patients of hepatocellular carcinoma (HCC) in India present in advanced stages, when curative treatment options are limited. We undertook this study to assess the cost-effectiveness of treating advanced HCC patients with sorafenib compared with best supportive care (BSC). MET...
Salvato in:
| Pubblicato in: | J Clin Exp Hepatol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728525/ https://ncbi.nlm.nih.gov/pubmed/31516263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.10.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|